Clinical Trial Update: Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for treating chronic hepatitis C in HIV-infected patients with pegylated interferon alfa-2a plus ribavirin. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: HIV Infections, Hepatitis C, Chronic | Phase 2 | Status: COMPLETED